Concord Medical Services Holdings Limited

NYSE:CCM Stock Report

Market Cap: US$19.3m

Concord Medical Services Holdings Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Concord Medical Services Holdings.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth20.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Positive Sentiment Still Eludes Concord Medical Services Holdings Limited (NYSE:CCM) Following 26% Share Price Slump

Sep 01
Positive Sentiment Still Eludes Concord Medical Services Holdings Limited (NYSE:CCM) Following 26% Share Price Slump

Investors Still Aren't Entirely Convinced By Concord Medical Services Holdings Limited's (NYSE:CCM) Revenues Despite 26% Price Jump

Jun 28
Investors Still Aren't Entirely Convinced By Concord Medical Services Holdings Limited's (NYSE:CCM) Revenues Despite 26% Price Jump

Investors Still Aren't Entirely Convinced By Concord Medical Services Holdings Limited's (NYSE:CCM) Revenues Despite 28% Price Jump

Apr 20
Investors Still Aren't Entirely Convinced By Concord Medical Services Holdings Limited's (NYSE:CCM) Revenues Despite 28% Price Jump

Concord Medical Services Holdings Limited's (NYSE:CCM) Shares Not Telling The Full Story

Dec 18
Concord Medical Services Holdings Limited's (NYSE:CCM) Shares Not Telling The Full Story

Concord Medical Services Holdings Limited (NYSE:CCM) Could Be Riskier Than It Looks

Aug 03
Concord Medical Services Holdings Limited (NYSE:CCM) Could Be Riskier Than It Looks

Concord Medical Non-GAAP EPS of -$0.14, revenue of $21.5M

Sep 26

What Type Of Shareholders Make Up Concord Medical Services Holdings Limited's (NYSE:CCM) Share Registry?

Jan 04
What Type Of Shareholders Make Up Concord Medical Services Holdings Limited's (NYSE:CCM) Share Registry?

Concord Medical divests Singapore-based Concord International Hospital

Dec 28

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Concord Medical Services Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NYSE:CCM - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2024472-379N/AN/AN/A
3/31/2024505-338N/AN/AN/A
12/31/2023537-298-396-276N/A
9/30/2023575-382N/AN/AN/A
6/30/2023612-466N/AN/AN/A
3/31/2023542-478N/AN/AN/A
12/31/2022472-490-601-217N/A
9/30/2022455-667N/AN/AN/A
6/30/2022437-845N/AN/AN/A
3/31/2022461-833N/AN/AN/A
12/31/2021486-821-1,140-359N/A
9/30/2021409-726N/AN/AN/A
6/30/2021333-631N/AN/AN/A
3/31/2021278-651N/AN/AN/A
12/31/2020223-670-735-230N/A
9/30/2020202-606N/AN/AN/A
6/30/2020182-541N/AN/AN/A
3/31/2020190-547N/AN/AN/A
12/31/2019198-553-897-195N/A
9/30/2019192-462N/AN/AN/A
6/30/2019185-371N/AN/AN/A
3/31/2019188-365N/AN/AN/A
12/31/2018191-359-802-39N/A
9/30/2018210-335N/AN/AN/A
6/30/2018230-311N/AN/AN/A
3/31/2018280-297N/AN/AN/A
12/31/2017331-284N/A27N/A
9/30/2017369-299N/AN/AN/A
6/30/2017407-313N/AN/AN/A
3/31/2017433-281N/AN/AN/A
12/31/2016455-262N/A-78N/A
9/30/2016492-322N/AN/AN/A
6/30/2016546-194N/AN/AN/A
3/31/2016591-139N/AN/AN/A
12/31/2015616-78N/A-175N/A
9/30/201540596N/AN/AN/A
6/30/2015504104N/AN/AN/A
3/31/2015615102N/AN/AN/A
12/31/201460799N/A490N/A
9/30/201455291N/AN/AN/A
6/30/20141,06199N/AN/AN/A
3/31/201450281N/AN/AN/A
12/31/201356375N/A259N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if CCM's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if CCM's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if CCM's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if CCM's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if CCM's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if CCM's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y